The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,432,632 in first-year total cost, median $770,445.
Most frequent study sections
- Special Emphasis Panel[ZTR1 TC-7 (01)]10
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- BRIGHAM AND WOMEN'S HOSPITAL1
- CEDARS-SINAI MEDICAL CENTER1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- JOHNS HOPKINS UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia1UG3TR003279-01 | PARKER, KEVIN KITPU, WILLIAM TSWENCHING | BOSTON CHILDREN'S HOSPITAL, MA | $875,700 | ZTR1 |
| 2020 | A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS1UG3TR003264-01 | SVENDSEN, CLIVE NIELS | CEDARS-SINAI MEDICAL CENTER, CA | $825,123 | ZTR1 |
| 2020 | Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems1UG3TR003288-01 | HIMMELFARB, JONATHANKRETZLER, MATTHIAS | UNIVERSITY OF WASHINGTON, WA | $818,669 | ZTR1 |
| 2020 | Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy1UG3TR003271-01 | KASS, DAVID ALANKIM, DEOK-HO | JOHNS HOPKINS UNIVERSITY, MD | $793,250 | ZTR1 |
| 2020 | Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics1UG3CA260692-01 | BEEBE, DAVID JLANG, JOSHUA MICHAEL | UNIVERSITY OF WISCONSIN-MADISON, WI | $775,417 | ZTR1 |
| 2020 | A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing1UG3TR003281-01 | AWAD, HANI AMCGRATH, JAMES LMILLER, BENJAMIN L | UNIVERSITY OF ROCHESTER, NY | $765,472 | ZTR1 |
| 2020 | A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease1UG3TR003289-01 | BEHARI, JAIDEEPSOTO-GUTIERREZ, ALEJANDROTAYLOR, D. LANSING | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $748,638 | ZTR1 |
| 2020 | Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip1UG3TR003283-01 | HAN, ARUMMENON, RAMKUMAR | TEXAS ENGINEERING EXPERIMENT STATION, TX | $691,020 | ZTR1 |
| 2020 | Clinical Trials in a Dish Using a Personalized Multi-Tissue Platform for Atopic Dermatitis1UG3AR079297-01 | CHRISTIANO, ANGELA M | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $599,999 | ZTR1 |
| 2020 | "Clinical Trials" on a Premature Vascular Aging-on-a-Chip Model1UG3TR003274-01 | ZHANG, Y. SHRIKE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $539,344 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.